Ausun Pharm
6032297.421.50% ( +0.11 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Ausun Pharm(603229) the Revenue is 308.67 M (+0.66%);the EBIT is 127.32 M (+0.67%);the EPS is 0.12 (-14.29%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.31B0.66%
----
----
EBIT
0.13B0.67%
----
----
EPS
0.1214.29%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf